Proven immune markers nevertheless preserve their relevance for medical final decision-creating in breast most cancers therapy with even prolonged meanings. Estrogen receptor (ER) stage must not only be categorized in beneficial or unfavorable. Low ER concentrations ?10% of labeled cells should be handled in different ways (LoE 1a/A/Back++). Tumors